Dose: 57.14 to 114.28 mg/kg
Single Dose: 86 (85.71)
Frequency: 8 hourly
Route: PO
Instructions: -

Dose: Notrecommended in this age group
Single Dose:
Frequency:
Route:
Instructions:

Dose: Should not be used under 12 years
Single Dose:
Frequency:
Route:
Instructions:

Benorylate also known as Fenasprate. . It is of Synthetic origin and belongs to Phenylbenzoate. It belongs to Cyclo-oxygenase inhibitor pharmacological group on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents pharmacological group.The Molecular Weight of Benorylate is 313.30.

Benorylate is contraindicated in conditions like Peptic ulcer.

The severe or irreversible adverse effects of Benorylate, which give rise to further complications include Hearing loss, Toxic hepatitis, Salicylism.The symptomatic adverse reactions produced by Benorylate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Nausea, Vomiting, Diarrhea, Constipation, Rashes, Indigestion, Heart burn.

Benorylate is primarily indicated in conditions like Dysmenorrhoea, Mild to moderate pain, Musculoskeletal disorders, Nausea and vomiting (palliative care), Osteoarthritis, Painful musculoskeletal conditions, Rheumatoid arthritis.

No data regarding the interactions of Benorylate was found.

Drug should not be given to Paediatrics, Pregnant Mothers, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab, Susp Store Below 40°C.

Benorylate should be used with caution in patients with renal or hepatic disease. The drug should not be used in neonates and during pregnancy and lactation, in individuals with known hypersensitivity to aspirin (including those with asthma, hemophilia, and similar coagulation disorders) or to acetaminophen.